81 related articles for article (PubMed ID: 8003286)
21. Inactivation of p53 enhances sensitivity to multiple chemotherapeutic agents.
Hawkins DS; Demers GW; Galloway DA
Cancer Res; 1996 Feb; 56(4):892-8. PubMed ID: 8631030
[TBL] [Abstract][Full Text] [Related]
22. Functional inactivation of p53 by human T-cell leukemia virus type 1 Tax protein: mechanisms and clinical implications.
Tabakin-Fix Y; Azran I; Schavinky-Khrapunsky Y; Levy O; Aboud M
Carcinogenesis; 2006 Apr; 27(4):673-81. PubMed ID: 16308315
[TBL] [Abstract][Full Text] [Related]
23. Expression of p53 and retinoblastoma gene in high-grade nodal peripheral T-cell lymphomas: immunohistochemical and molecular findings suggesting different pathogenetic pathways and possible clinical implications.
Pescarmona E; Pignoloni P; Santangelo C; Naso G; Realacci M; Cela O; Lavinia AM; Martelli M; Russo MA; Baroni CD
J Pathol; 1999 Aug; 188(4):400-6. PubMed ID: 10440751
[TBL] [Abstract][Full Text] [Related]
24. p53: an overview of over two decades of study.
Cheah PL; Looi LM
Malays J Pathol; 2001 Jun; 23(1):9-16. PubMed ID: 16329542
[TBL] [Abstract][Full Text] [Related]
25. Expression of p53 protein in T- and natural killer-cell lymphomas is associated with some clinicopathologic entities but rarely related to p53 mutations.
Petit B; Leroy K; Kanavaros P; Boulland ML; Druet-Cabanac M; Haioun C; Bordessoule D; Gaulard P
Hum Pathol; 2001 Feb; 32(2):196-204. PubMed ID: 11230707
[TBL] [Abstract][Full Text] [Related]
26. Expression of the retinoblastoma (RB) tumor suppressor gene inhibits tumor cell invasion in vitro.
Li J; Hu SX; Perng GS; Zhou Y; Xu K; Zhang C; Seigne J; Benedict WF; Xu HJ
Oncogene; 1996 Dec; 13(11):2379-86. PubMed ID: 8957079
[TBL] [Abstract][Full Text] [Related]
27. Sodium butyrate modulates p53 and Bcl-2 expression in human retinoblastoma cell lines.
Madigan MC; Chaudhri G; Penfold PL; Conway RM
Oncol Res; 1999; 11(7):331-7. PubMed ID: 10757447
[TBL] [Abstract][Full Text] [Related]
28. Tumour p53 mutations exhibit promoter selective dominance over wild type p53.
Monti P; Campomenosi P; Ciribilli Y; Iannone R; Inga A; Abbondandolo A; Resnick MA; Fronza G
Oncogene; 2002 Mar; 21(11):1641-8. PubMed ID: 11896595
[TBL] [Abstract][Full Text] [Related]
29. Role of the retinoblastoma protein in cell cycle arrest mediated by a novel cell surface proliferation inhibitor.
Enebo DJ; Fattaey HK; Moos PJ; Johnson TC
J Cell Biochem; 1994 Jun; 55(2):200-8. PubMed ID: 8089195
[TBL] [Abstract][Full Text] [Related]
30. Acute mutation of retinoblastoma gene function is sufficient for cell cycle re-entry.
Sage J; Miller AL; Pérez-Mancera PA; Wysocki JM; Jacks T
Nature; 2003 Jul; 424(6945):223-8. PubMed ID: 12853964
[TBL] [Abstract][Full Text] [Related]
31. The Pezcoller lecture: cancer cell cycles revisited.
Sherr CJ
Cancer Res; 2000 Jul; 60(14):3689-95. PubMed ID: 10919634
[TBL] [Abstract][Full Text] [Related]
32. Gain-of-function mutations in the tumor suppressor gene p53.
van Oijen MG; Slootweg PJ
Clin Cancer Res; 2000 Jun; 6(6):2138-45. PubMed ID: 10873062
[TBL] [Abstract][Full Text] [Related]
33. Tumour suppressor genes and molecular chaperones.
Lane DP; Midgley C; Hupp T
Philos Trans R Soc Lond B Biol Sci; 1993 Mar; 339(1289):369-72; discussion 372-3. PubMed ID: 8493291
[TBL] [Abstract][Full Text] [Related]
34. Infrequent alternations of RB pathway (Rb-p16INK4A-cyclinD1) in adenoid cystic carcinoma of salivary glands.
Shintani S; Mihara M; Nakahara Y; Kiyota A; Yoshihama Y; Ueyama Y; Matsumura T
Anticancer Res; 2000; 20(3B):2169-75. PubMed ID: 10928172
[TBL] [Abstract][Full Text] [Related]
35. Cooperative tumorigenic effects of germline mutations in Rb and p53.
Williams BO; Remington L; Albert DM; Mukai S; Bronson RT; Jacks T
Nat Genet; 1994 Aug; 7(4):480-4. PubMed ID: 7951317
[TBL] [Abstract][Full Text] [Related]
36. [Cell cycle regulation by anti-oncogene].
Akiyama T
Tanpakushitsu Kakusan Koso; 1994 Sep; 39(12):2158-62. PubMed ID: 7938611
[No Abstract] [Full Text] [Related]
37. [Molecular cancer epidemiology--the present status and future possibilities].
Sakai T
Nihon Eiseigaku Zasshi; 1996 Feb; 50(6):1036-46. PubMed ID: 8720930
[TBL] [Abstract][Full Text] [Related]
38. The role of the p53 and Rb-1 genes in cancer, development and apoptosis.
Hooper ML
J Cell Sci Suppl; 1994; 18():13-7. PubMed ID: 7883788
[TBL] [Abstract][Full Text] [Related]
39. Tumor suppressor genes: a new era for molecular genetic studies of cancer.
Lee EY
Breast Cancer Res Treat; 1991 Sep; 19(1):3-13. PubMed ID: 1756264
[TBL] [Abstract][Full Text] [Related]
40. The Knights of the Round Table hypothesis of tumour suppressor gene function--noble sacrifice or sexual dalliance: genes, including p53, BRCA1/2 and RB have evolved by horizontal and vertical transmission of mating factor genes and are involved in gametogenesis, implantation, development and tumourigenesis.
Gosden CM; Liloglou T; Nunn J; Gardener D; Nickson P; Crampton JM; Field JK
Int J Oncol; 1998 Jan; 12(1):5-35. PubMed ID: 9454883
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
